WESTLAKE VILLAGE, Calif. and DANBURY, Conn., April 19, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics (Nasdaq: UTHR) reached a milestone today in the development ...
What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...
The Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension ...
Patients who switched from a pressurized metered dose inhaler (pMDIs) to a dry powder inhaler (DPI) halved their carbon footprints while still maintaining good asthma control, a post-hoc analysis of ...
MannKind celebrates that the FDA has approved United Therapeutics’ Tyvaso DPI™ (treprostinil) inhalation powder Tyvaso DPI™ production is underway at MannKind Corporation (Nasdaq: MNKD) in Danbury, ...
Watford, England, May 24, 2021: Glenmark Pharmaceuticals is changing the design of its Stalpex (salmeterol xinafoate/fluticasone propionate) inhaler. The external shape of the dry powder inhaler will ...
What is a dry powder inhaler? Some medications can be taken in the form of a dry powder, using a dry powder inhaler, which is also a handheld device. A DPI delivers medication to the lungs as you ...
A simple, one-part DPI aims to make inhalation drug treatment more accessible and affordable. Hovione Technology, a Hovione Ventures company, announced in an April 15, 2019 press release that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback